Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, March 31, 2025.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Crossroads (-60) - LGND is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid LGND?
MarketClub looks at technical strength and momentum to determine if the timing is right for LGND.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for LGND
The long-term trend has been UP since Dec 14th, 2023 at 67.48
The intermediate-term trend has been DOWN since Mar 3rd, 2025 at 110.42
The short-term trend has been DOWN since Mar 28th, 2025 at 107.61
Smart Scan Analysis for LGND
Based on our trend formula, LGND is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 105.5500 | 106.3739 | 103.0600 | 104.9450 | -2.6750 |
| Prev. Close | Volume | Bid | Ask | Time |
| 107.6200 | 109709 | 2025-03-31 15:59:43 |
| Year High | 278.62 | Year High Date | 2018-10-01 |
| Year Low | 136.75 | Year Low Date | 2018-01-02 |
| 52wk High | 129.9 | 52wk High Date | 2024-11-07 |
| 52wk Low | 67.72 | 52wk Low Date | 2024-04-22 |
| Year End Close | 20.74 | Average Volume | 135,233 |
| Shares Outstanding | 36,961 | Short Interest | 1,453,838 |
| % Institutional | 78.4 | Market Cap | 1,745M |
| Assets | 941,774,000M | Liabilities | 111,335,000M |
| Beta | 1.21 | Volatility | 56.27 |